title: Validation parameters cannot be obtained without using pure substance.
authors.forename: Kim C M
authors.initials: KC
authors.lastname: van der Elst
authors.forename: Donald R A
authors.initials: DR
authors.lastname: Uges
authors.forename: Jan-Willem C
authors.initials: JW
authors.lastname: Alffenaar
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D017291:Clarithromycin / Q000493:pharmacokinetics*; D006734:Horse Diseases / Q000097:blood* / Q000188:drug therapy*; D011650:Pulmonary Alveoli / Q000378:metabolism*; D012141:Respiratory Tract Infections / Q000662:veterinary*; D012293:Rifampin / Q000493:pharmacokinetics*
chemical_list: D000900:Anti-Bacterial Agents; D017291:Clarithromycin; D012293:Rifampin